Serum Institute of India (SII) and Bharat Biotech today pledged “a smooth rollout of Covid-19 vaccines to India and the world”.

Twenty people have died from Covid-19 in 24 hours (till 8am today), according to a press release issued by the Directorate General of Health Services (DGHS).

Coronavirus vaccine developed by AstraZeneca and the University of Oxford will cost USD three to four per shot (Rs 219-292) to the Indian government and will be priced at double that rate in private market once such sales open up, reports PTI quoting the CEO of its Indian manufacturer as saying on Monday.

British Prime Minister Boris Johnson on Monday ordered England into a new national lockdown to contain a surge in Covid-19 cases that threatens to overwhelm parts of the health system before a vaccine programme reaches a critical mass.

Mexico approved the Oxford-AstraZeneca coronavirus vaccine for emergency use Monday, hoping to spur a halting vaccination effort that has only given about 44,000 shots since the third week of December, about 82percent of the doses the country has received.

Bangladesh has approved the Oxford University-AstraZeneca coronavirus vaccine manufactured by Serum Institute of India, paving the way for bringing the vaccine for emergency use.

Beximco Pharmaceuticals Ltd. has received approval from the Directorate General of Drug Administration (DGDA) to import the Oxford-AstraZeneca Covid-19 vaccine.

India’s Ministry of External Affairs has confirmed that the ban on Covid-19 vaccine export will not be applicable for Bangladesh, Foreign Minister AK Abdul Momen has said.

Twenty-four people have died from Covid-19 in 24 hours (till 8am today), according to a press release issued by the Directorate General of Health Services (DGHS).

Health Minister Zahid Maleque has said the government expects Covid-19 vaccines from the Serum Institute of India on time.

A flight carrying 48 passengers from London landed today in Sylhet’s Osmani International Airport and 42 of them were put under institutional quarantine to curb the new strain of coronavirus.

Beximco Pharmaceuticals, the local partner of Serum Institute of India (SII), has said that Bangladesh will get three crore doses of Covid-19 vaccines on time.

Britain will become the first country to roll out the low cost and easily transportable AstraZeneca and Oxford University Covid-19 vaccine on Monday, another step forward in the global response to the pandemic.

Serum Institute of India (SII), the Indian manufacturer of the AstraZeneca/Oxford coronavirus vaccine, has said it intends to concentrate on meeting India’s own immediate demand in the next two months before exporting to other interested countries.

India’s drugs regulator on Sunday gave final approval for the emergency use of a two-dose coronavirus vaccine, COVISHIELD, developed by AstraZeneca and Oxford University. The regulator did not discuss the recommended intervals between shots.

India granted emergency approval to Bharat Biotech’s COVAXIN but faced questions after taking the step without publishing efficacy data for the homegrown coronavirus vaccine.

Twenty-seven people have died from Covid-19 in the last 24 hours (till 8:00am today), according to a press release issued by the Directorate General of Health Services (DGHS).

Tokyo's governor on Saturday asked Japan's central government to declare a new state of emergency as the country battles a third wave of the coronavirus, with record numbers of new cases.

Health Minister Zahid Maleque has said Bangladesh will be able to procure the Covid-19 vaccine at a lower cost compared to many other countries due to the government’s prompt decision to this end.

Britain will allow people to be given shots of different COVID-19 vaccines on rare occasions, despite a lack of evidence about the extent of immunity offered by mixing doses.